Smith & Nephew SNATS Long Term Debt 2010-2024 | SNN

Smith & Nephew SNATS long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Smith & Nephew SNATS long term debt for the quarter ending December 31, 2024 was $3.258B, a 42.83% increase year-over-year.
  • Smith & Nephew SNATS long term debt for 2024 was $3.258B, a 40.49% increase from 2023.
  • Smith & Nephew SNATS long term debt for 2023 was $2.319B, a 14.49% decline from 2022.
  • Smith & Nephew SNATS long term debt for 2022 was $2.712B, a 4.78% decline from 2021.
Smith & Nephew SNATS Annual Long Term Debt
(Millions of US $)
2024 $3,258
2023 $2,319
2022 $2,712
2021 $2,848
2020 $3,353
2019 $1,975
2018 $1,301
2017 $1,423
2016 $1,564
2015 $1,434
2014 $1,666
2013 $347
2012 $430
2011 $16
2010 $642
2009 $1,090
Smith & Nephew SNATS Quarterly Long Term Debt
(Millions of US $)
2024-12-31 $3,258
2023-12-31 $2,319
2023-06-30 $2,633
2022-12-31 $2,712
2022-06-30 $2,281
2021-12-31 $2,848
2021-06-30 $2,916
2020-12-31 $3,353
2020-06-30 $2,476
2019-12-31 $1,975
2019-06-30 $1,980
2018-12-31 $1,301
2018-06-30 $1,420
2017-12-31 $1,423
2017-06-30 $1,604
2016-12-31 $1,564
2015-12-31 $1,434
2015-06-30 $1,532
2014-12-31 $1,666
2014-09-30 $1,936
2014-06-30 $1,986
2014-03-31 $337
2013-12-31 $347
2013-09-30 $289
2013-06-30 $335
2013-03-31 $209
2012-12-31 $430
2012-09-30 $16
2012-06-30 $15
2012-03-31 $15
2011-12-31 $16
2011-09-30 $16
2011-06-30 $18
2011-03-31 $528
2010-12-31 $642
2010-09-30 $1,054
2010-06-30 $1,045
2010-03-31 $1,014
2009-12-31 $1,090
2009-09-30 $1,229
2009-06-30 $1,267
2009-03-31 $1,163
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $12.272B $5.810B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $226.763B 27.35
Boston Scientific (BSX) United States $152.152B 38.10
Stryker (SYK) United States $142.721B 30.67
EssilorLuxottica (ESLOY) France $133.556B 0.00
Medtronic (MDT) Ireland $108.708B 15.87
Lonza Group Ag (LZAGY) Switzerland $51.613B 0.00
Haleon (HLN) United Kingdom $45.796B 26.03
ResMed (RMD) United States $34.691B 26.06
GE HealthCare Technologies (GEHC) United States $32.200B 15.29
Agilent Technologies (A) United States $30.677B 20.26
Terumo (TRUMY) Japan $28.397B 0.00
Koninklijke Philips (PHG) Netherlands $23.827B 17.01
Zimmer Biomet Holdings (ZBH) United States $20.388B 12.88
Insulet (PODD) United States $17.717B 75.76
Baxter (BAX) United States $15.988B 11.50
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Demant (WILYY) Denmark $7.600B 0.00
Lantheus Holdings (LNTH) United States $7.145B 17.57
Bio-Rad Laboratories (BIO) United States $6.837B 23.67
Prestige Consumer Healthcare (PBH) United States $4.024B 19.20
Perrigo (PRGO) Ireland $3.510B 10.05
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.362B 28.64
Haemonetics (HAE) United States $3.166B 14.90
Envista Holdings (NVST) United States $2.725B 22.03
GN Store Nord (GNNDY) Denmark $2.260B 18.72
LeMaitre Vascular (LMAT) United States $2.050B 46.77
QuidelOrtho (QDEL) United States $1.875B 15.70
AtriCure (ATRC) United States $1.480B 0.00
Green Thumb Industries (GTBIF) United States $1.401B 22.00
Kestra Medical Technologies (KMTS) United States $1.235B 0.00
AdaptHealth (AHCO) United States $1.148B 11.05
BioLife Solutions (BLFS) United States $1.145B 0.00
Neogen (NEOG) United States $1.096B 14.03
InMode (INMD) Israel $0.981B 8.98
Phibro Animal Health (PAHC) United States $0.754B 11.56
Evolus (EOLS) United States $0.735B 0.00
Curaleaf Holdings (CURLF) Canada $0.713B 0.00
Capricor Therapeutics (CAPR) United States $0.580B 0.00
CeriBell (CBLL) United States $0.577B 0.00
Owens & Minor (OMI) United States $0.545B 4.64
Valneva SE (VALN) France $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.488B 0.00
Cresco Labs (CRLBF) United States $0.479B 0.00
Omeros (OMER) United States $0.427B 0.00
Surmodics (SRDX) United States $0.400B 0.00
SNDL (SNDL) Canada $0.392B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.357B 0.00
VAREX IMAGING (VREX) United States $0.343B 14.86
Verano Holdings (VRNOF) United States $0.323B 0.00
Sanara MedTech (SMTI) United States $0.284B 0.00
Viemed Healthcare (VMD) United States $0.279B 25.25
Aurora Cannabis (ACB) Canada $0.261B 46.40
Canopy Growth (CGC) Canada $0.254B 0.00
Cerus (CERS) United States $0.252B 0.00
ZimVie (ZIMV) United States $0.252B 15.10
OraSure Technologies (OSUR) United States $0.232B 0.00
Sanuwave Health (SNWV) United States $0.231B 0.00
Quanterix (QTRX) United States $0.223B 0.00
High Tide (HITI) Canada $0.195B 0.00
Biote (BTMD) United States $0.182B 4.16
Utah Medical Products (UTMD) United States $0.170B 13.69
TriSalus Life Sciences (TLSI) United States $0.166B 0.00
Brainsway (BWAY) Israel $0.164B 51.00
Organigram Global (OGI) Canada $0.146B 0.00
Jin Medical (ZJYL) China $0.142B 0.00
FitLife Brands (FTLF) United States $0.142B 17.46
TerrAscend (TSNDF) Canada $0.128B 0.00
Agape ATP (ATPC) $0.115B 0.00
Exagen (XGN) United States $0.112B 0.00
MacroGenics (MGNX) United States $0.109B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.093B 0.00
Jushi Holdings (JUSHF) United States $0.082B 0.00
Veru (VERU) United States $0.079B 0.00
Fonar (FONR) United States $0.078B 10.91
InterCure (INCR) Israel $0.072B 0.00
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
Zynex (ZYXI) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Apyx Medical (APYX) United States $0.039B 0.00
Safety Shot (SHOT) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.037B 54.00
United-Guardian (UG) United States $0.036B 11.14
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00